Schweitzer Fachinformationen
Wenn es um professionelles Wissen geht, ist Schweitzer Fachinformationen wegweisend. Kunden aus Recht und Beratung sowie Unternehmen, öffentliche Verwaltungen und Bibliotheken erhalten komplette Lösungen zum Beschaffen, Verwalten und Nutzen von digitalen und gedruckten Medien.
Hans G. Beger MD, FACS, Emeritus Professor of Surgery, Universitätsklinikum Ulm, Universität Ulm, Ulm, Germany.
Akimasa Nakao MD, PhD, FACS, Professor Emeritus, Nagoya University; President, Nagoya Central Hospital, Nagoya, Japan.
John P. Neoptolemos MA, MB, BChir, MD, FRCS, FMedSci, The Owen and Ellen Evans Chair of Surgery; NIHR Senior Investigator; NIHR Liverpool Pancreas Biomedical Research Unit, The Liverpool Clinical Trials Unit and Cancer Research UK; Cancer Trials Unit Director, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Shu You Peng MD, FACS, FRCSG, ESA, Professor, Department of Surgery, Second Affi liated Hospital, Zhejiang University, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
Michael G. Sarr MD, J.C. Masson Professor of Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Section 1: Ductal Adenocarcinoma of the Pancreas
1. Histologic Classification and Tumor Staging of Pancreatic CancerAkio Yanagisawa and Eiichi Konishi
2. What We Know about Carcinogenesis of Ductal Adenocarcinoma of the PancreasC. J. Bruns, H. Niess, B. Schwarz, A. Kleespies, M. K. Angele and K.-W. Jauch
3. Familiar Cancer of the PancreasDetlef K. Bartsch, Volker Fendrich and Peter Langer
4. Clinical, Laboratory and Radiologic Presentation of Pancreatic CancerSusumu Hijioka and Kenji Yamao
5. Standards of Oncologic Pancreatic SurgeryZhi Ven Fong and Keith D. Lillemoe
6. Extended Resection for Pancreatic Cancer: Risk and BenefitsAkimasa Nakao
7. Risk/Benefit of Total Pancreatectomy for Pancreatic Cancer: Are There Indications?Ake Andrén-Sandberg and Ralf Segersvard
8. Is There a Benefit for Additional Arterial Resection of Ductal Cancer of the Pancreas?Satoshi Hirano and Takahiro Tsuchikawa
9. Who Benefits from Ultra-Radical Pancreatic Cancer Extirpation?Akimasa Nakao
10. Risk and Results of Pancreatic Cancer ResectionNorbert Hüser, Volker Assfalg and Helmut Friess
11. Pancreatic Cancer: The Role of Bypass ProceduresJ.A.M.G. Tol, O.R.C. Busch, T.M. van Gulik and D.J. Gouma
12. Evidence of Adjuvant Chemotherapy of Ductal Pancreatic CancerAsma Sultana, Christopher Halloran, Daniel Palmer, Paula Ghaneh Trevor Cox and John P Neoptolemos
13. Neoadjuvant Chemo- and Radio-Chemotherapy: Is There a Survival Advantage for Pancreatic Cancer PatientsSusan Tsai, Ben George, Kathleen K. Christians and Douglas B. Evans
14. Standards of Palliative Chemotherapy and Chemoradiotherapy of Local Advanced Pancreatic Cancer, Side Effects and Survival BenefitsHana Algül and Roland M. Schmid
15. Management of Local and Distant Recurrence after Pancreatic Cancer ResectionTakuji Okusaka, Kenji Hashimoto, Tomoko Katsui Taniyama, Hideki Ueno, Chigusa Morizane, Shunsuke Kondo, Shuichi Mitsunaga, Satoshi Shimizu, Izumi Ohno, Hideaki Takahashi and Masafumi Ikeda
16. Survival 3-, 5- and 10-years after Adjuvant Regional and Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer Patients: an Institutional ExperienceOsamu Ishikawa, Hiroaki Ohhigashi and Hidenori Takahashi
17. Non-ductal Primary Malignancies of the Pancreas: Acinus Cell CarcinomaMarius Distler and Robert Grutzmann
18.Non-ductal Primary Malignancies of the Pancreas: Metastatic MalignanciesVictor Zaydfudim, Michael B. Farnell and Michael G. Sarr
Section 2: Periampullary Cancers
19. Histopathology of Tumor of the Ampulla of VaterLi-rong Chen
20. Clinics of Periampulary CancerCai Xiujun
21. Adenoma of the Papilla of Vater and Endoscopic ManagementTakao Itoi and Shujiro Tsuji
22. Controversies about Local or Regional Treatment of Adenoma of the Papilla of Vater: Japanese ExperienceTakehiro Ota, Masakazu Yamamoto and Ken Takasaki
23. Cancer of the Papilla: Surgical ManagementHans G. Beger Q L Qiao and B Poch
24. Evidence of Surgical Management of Distal Common Bile Duct CancerYingbin Liu and Wenguang Wu
25. Evidence of Surgical Management of Duodenum CancerRory L. Smoot and Florencia G. Que
26. Survival and Chance of Cure after Surgery, Adjuvant and Palliative Chemotherapy of Periampullary TumorsHao ran Qian and Shu You Peng
Section 3: Cystic Neoplastic Lesion of the Pancreas
27. Histologic Classification and Staging of Cystic Neoplastic Lesions of the PancreasRondell Graham and Tom Smyrk
28. Clinical Presentation of Cystic Neoplasms of the PancreasMasao Tanaka
29. EUS and Cystic Fluid Analysis of the Pancreas: Evidence of Diagnostic MeasuresWon Jae Yoon and William R. Brugge
30. Natural History of IPMN: Adenoma/Carcinoma Sequence in IPMNMasanori Sugiyama and Yutaka Suzuki
31. What are the Pathologic Criteria that Justified Observational Management in Patients with Cystic Naoplastic Lesions of the Pancreas?Klaus Sahora, and Carlos Fernández-del Castillo
32. Indication for Operative Intervention of Cystic Neoplasms of the PancreasGeorge H. Sakorafas and Vassileios Smyrniotis
33. Surgical Management of IPMN Lesions of the PancreasMarcus C.B. Tan and Peter J. Allen
34. Surgical Management of MCN Lesions of the PancreasKlaus Sahora and Carlos Fernández-del Castillo
35. Surgical Management of SCA of the PancreasGiuseppe Malleo, Claudio Bassi and Roberto Salvia
36. Surgical Management of SPsN of the PancreasSong Cheol Kim
37. Limited Oncologic Resection or Major Surgery of Cystic Neoplasms of the Pancreas?Hans G Beger, Yang Yinmo, and Akimasa Nakao
38. Enucleation of Cystic Neaplasia of the Pancreas?Janak A. Parikh and C. Max Schmidt
39. Long-Term Outcome after Observation and Surgical Treatment of the Cystic Neoplasms of the PancreasGiuseppe Malleo, Roberto Salvia and Claudio Bassi
Section IV: Endocrine Neoplasms of the Pancreas
40. Classification of Endocrine Tumors of the PancreasJ. J. Mukherjee and K. O. Lee
41. Clinical Manifestation of Endocrine Tumors of the PancreasK. O. Lee
42. Evidence of Hormonal, Laboratory, Bio-Chemistric and Instrumental Diagnostics of Endocrine Tumors of the PancreasC.E.D.Ng, J. J. Mukherjee and K.O. Lee
43. Evidence of Medical and Radionucleotide Treatment of Endocrine Tumors of the PancreasDavid C.E. Ng., J. J. Mukherjee and K.O. Lee
44. Insulinoma: Evidence of Surgical TreatmentY. P. Mou
45. Gastrinoma: Evidence of Surgical TreatmentR. Y. Qin
46. Rare Endocrine Tumors of the Pancreas: Evidence of ManagementJiang Tao Li, Shu You Peng and De Fei Hong
47. Long-term Outcome after Clinical Management of Endocrine Tumors of the PancreasBin Xu and Jian Wei Wang
Section V: Chronic Pancreatitis with Inflammatory Tumor of the Pancreas
48. Chronic Pancreatitis with Inflammatory Mass in the Pancreatic HeadUlrich F. Wellner and Tobias Keck
49. Chronic Tropical Pancreatitis: Clinical syndromes, natural course management principlesSavio G. Barreto and Shailesh V. Shrikhande
50. Laboratory, Endoscopic and Radiologic Diagnostic of Chronic Pancreatitis with Inflammatory Mass in the HeadJ. Enrique Domínguez-Munoz, Julio Iglesias-Garcia and José Larino-Noia
51. Autoimmune Pancreatitis : How to Recognize this Entity and Avoid Surgical TreatmentRaghuwansh P. Sah and Suresh T. Chari
52. What is the Place of Interventional-Endoscopic Treatment in Chronic Pancreatitis/Inflammatory Tumor of the Pancreatic Head?Yoshiki Hirooka and Hidemi Goto
53. When to Change from Conservative to Surgical Management in Alcoholic Chronic and Tropical Chronic PancreatitisShailesh V. Shrikhande and Savio G. Barreto
54. Duodenum Preserving Pancreatic Head Resection of Chronic Pancreatits with Inflammatory MassHans G. Beger and Qiao Qilu
55. Major Resection for Chronic PancreatitisJohn C. McAuliffe and John D. Christein
56. Short-term and Long-term Outcome after Interventional and Surgical Treatment of Chronic Pancreatitis with Inflammatory MassVolker Assfalg, Norbert Hüser and Helmut Friess
Dateiformat: PDFKopierschutz: Adobe-DRM (Digital Rights Management)
Systemvoraussetzungen:
Das Dateiformat PDF zeigt auf jeder Hardware eine Buchseite stets identisch an. Daher ist eine PDF auch für ein komplexes Layout geeignet, wie es bei Lehr- und Fachbüchern verwendet wird (Bilder, Tabellen, Spalten, Fußnoten). Bei kleinen Displays von E-Readern oder Smartphones sind PDF leider eher nervig, weil zu viel Scrollen notwendig ist. Mit Adobe-DRM wird hier ein „harter” Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.
Bitte beachten Sie: Wir empfehlen Ihnen unbedingt nach Installation der Lese-Software diese mit Ihrer persönlichen Adobe-ID zu autorisieren!
Weitere Informationen finden Sie in unserer E-Book Hilfe.
